Securities Class Action
Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
Zenas BioPharma, Inc. (ZBIO) Class Action Lawsuit (April 2025)
Closed1:25cv10988 • April 16, 2025
Class Period Start
September 13, 2024
Class Period End
April 16, 2025
PSLRA Deadline
June 16, 2025
Case Allegations
Sec11
Statutes of Repose
Sep 13, 2027
Country
United States
Court
Federal Court
Docket History
Aug 3, 2026
Jun 29, 2026
Motion to Dismiss Granted (opens in a new tab)
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Jan 23, 2026
Motion to Dismiss (opens in a new tab)
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Nov 21, 2025
First Amended Complaint (opens in a new tab)
A new complaint has been filed on behalf of certain investors in Zenas BioPharma, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Aug 21, 2025
Appointment of Lead Plaintiff (opens in a new tab)
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.